Cargando…

Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy

Receptors on T and NK cells systematically propagate highly complex signaling cascades that direct immune effector functions, leading to protective immunity. While extensive studies have delineated hundreds of signaling events that take place upon receptor engagement, the precise molecular mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajasekaran, Kamalakannan, Riese, Matthew J., Rao, Sridhar, Wang, Li, Thakar, Monica S., Sentman, Charles L., Malarkannan, Subramaniam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863891/ https://www.ncbi.nlm.nih.gov/pubmed/27242783 http://dx.doi.org/10.3389/fimmu.2016.00176

Ejemplares similares

IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection
por: Kumar, Pawan, et al.
Publicado: (2019)

Clinical Relevance of Natural Killer Cells Following Hematopoietic Stem Cell Transplantation
por: Palmer, Jeanne M, et al.
Publicado: (2012)

IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration
por: Kumar, Pawan, et al.
Publicado: (2012)

The Fyn–ADAP Axis: Cytotoxicity Versus Cytokine Production in Killer Cells
por: Gerbec, Zachary J., et al.
Publicado: (2015)

Natural Killer Cells: Development, Maturation, and Clinical Utilization
por: Abel, Alex M., et al.
Publicado: (2018)

Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature
por: Yang, Chao, et al.
Publicado: (2020)

Fyn-ADAP signaling via Carma1-Bcl10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2013)

Implementing Logic Gates for Safer Immunotherapy of Cancer
por: Savanur, Mohammed Azharuddin, et al.
Publicado: (2021)

Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8(+) T Cells
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2010)

mTORC1 and mTORC2 differentially promote natural killer cell development
por: Yang, Chao, et al.
Publicado: (2018)

Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
por: Thakar, Monica S., et al.
Publicado: (2020)

IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells
por: Abel, Alex M., et al.
Publicado: (2018)

IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection
por: Kumar, Pawan, et al.
Publicado: (2012)

Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function
por: Yea, Sung Su, et al.
Publicado: (2014)

Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity
por: Sitaram, Poojitha, et al.
Publicado: (2019)

γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection
por: Shiromizu, Carolina Maiumi, et al.
Publicado: (2018)

Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
por: Yang, Chao, et al.
Publicado: (2019)

Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes
por: Awasthi, Aradhana, et al.
Publicado: (2010)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Conditional Deletion of PGC-1α Results in Energetic and Functional Defects in NK Cells
por: Gerbec, Zachary J., et al.
Publicado: (2020)

Lipid and Protein Co-Regulation of PI3K Effectors Akt and Itk in Lymphocytes
por: Wang, Xinxin, et al.
Publicado: (2015)

Die Kämpfe únd schláchten—the struggles and battles of innate-like effector T lymphocytes with microbes
por: Joyce, Sebastian, et al.
Publicado: (2023)

Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
por: Wu, Lan, et al.
Publicado: (2023)

Ancient but Not Forgotten: New Insights Into MPEG1, a Macrophage Perforin-Like Immune Effector
por: Bayly-Jones, Charles, et al.
Publicado: (2020)

Cytotoxic T lymphocyte effector function is independent of nucleus–centrosome dissociation
por: Lui-Roberts, Winnie W Y, et al.
Publicado: (2012)

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
por: Burger, Michael C., et al.
Publicado: (2019)

Towards better and safer blood transfusion
por: Cho, Duck
Publicado: (2013)

Towards safer use of pesticides in Chile
por: Coria, Jessica, et al.
Publicado: (2022)

Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice
por: Kaur, Kawaljit, et al.
Publicado: (2023)

Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway
por: Idso, John M., et al.
Publicado: (2020)

Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy
por: McPherson, Rhoanne C, et al.
Publicado: (2014)

HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
por: Hoerster, Keven, et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
por: Bai, Ziyi, et al.
Publicado: (2022)

Spoiling for a Fight: B Lymphocytes As Initiator and Effector Populations within Tertiary Lymphoid Organs in Autoimmunity and Transplantation
por: Alsughayyir, Jawaher, et al.
Publicado: (2017)

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
por: Nelde, Annika, et al.
Publicado: (2021)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression
por: Reimer, Michael, et al.
Publicado: (2019)

Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells
por: Luo, Xiaofeng, et al.
Publicado: (2018)

Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2014)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mo6m6fmmnv7q7f9rmeav8none2